Journal ArticleOPEN ACCESS

Normocomplementaemic urticarial vasculitis: Effective treatment with omalizumab

Clinical and Translational Allergy (2018) 8(1)
DOI: 10.1186/s13601-018-0222-y
24Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report two patients with normocomplementaemic urticarial vasculitis with impressive response to omalizumab. This contrasts recent reports on hypocomplementaemic urticarial vasculitis syndrome, highlighting the need for clinical trials of omalizumab in normocomplementaemic urticarial vasculitis.

Author supplied keywords

Cite

CITATION STYLE

APA

De Brito, M., Huebner, G., Murrell, D., Bullpitt, P., & Hartmann, K. (2018). Normocomplementaemic urticarial vasculitis: Effective treatment with omalizumab. Clinical and Translational Allergy, 8(1). https://doi.org/10.1186/s13601-018-0222-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free